HEAL
Reasons to Consider HEAL
High Growth Potential
The healthcare sector is under strain due to rising demand from an aging population and workforce shortages. Technology presents a viable solution, with the size of the HealthTech market expected to exceed $1T by 2032.1
Healthcare Innovators
The Fund invests in companies at the intersection of healthcare and technology across four key sub-themes: healthcare analytics and software, smart medical devices, AI drug discovery, and tech-enabled consumer healthcare.
Timely Opportunity
A growing range of technologies are set to advance patient care, evidenced by increased AI device approvals, lower drug development costs and optimized administrative processes that are improving clinical workflows.
1Global X ETFs Forecasts, Mar 2025
| Key Information |
ETF Summary
The Global X HealthTech ETF (HEAL) invests in companies transforming healthcare through cutting-edge technology. The fund targets four sub-themes: AI-enabled drug discovery, smart medical devices, tech-enabled consumer healthcare, and healthcare analytics and software solutions. Companies in these areas harness advanced technologies to enhance patient care, streamline operations, and drive medical breakthroughs. By focusing on tech-driven innovation, HEAL seeks to provide exposure to firms shaping the future of healthcare.
ETF Objective
The Global X HealthTech ETF (HEAL) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Global X HealthTech Index.
Trading Details
As of Jun 12 2025| Distributions |
ETF Prices
As of Jun 13 2025| NAV | $10.58 | Daily Change | -$0.17 | -1.58% |
| Market Price | $10.58 | Daily Change | -$0.19 | -1.76% |
Performance History
| Fund NAV | Market Price | Index | |
|---|---|---|---|
Top Holdings
| Net Assets (%) | Ticker | Name | SEDOL | Shares Held | Market Value |
|---|---|---|---|---|---|
Exposure
As of May 31 2025| Sector | Weight (%) | |
|---|---|---|
| Health Care | 94.9 | |
| Materials | 2.7 | |
| Financials | 2.3 | |
| Other | 0.1 |
ETF Characteristics
As of Jun 13 2025| Return on Equity | 6.50% | |
| Weighted Avg. Market Cap | 18,780 M | |
| 2024 | 2025 | |
| Price-to-earnings | -529.00 | 75.57 |
| Price-to-book value | 5.14 | 4.68 |
ETF Risk Stats
As of May 31 2025| VERSUS | BETA |
|---|---|
| S&P 500 | 1.17 |
| NASDAQ-100 | 0.85 |
| MSCI EAFE | 0.96 |
| MSCI Emg. Mkts | 0.80 |
| Standard Deviation | 25.60% |
ETF Research
ETF Documents
Prospectus & Regulatory Information
* The financial statements include the Fund’s disclosures required by Items 7 through 11 of Form N-CSR, which includes the financial statements, financial highlights, and other important information when applicable.
** The financial statements include the Fund’s disclosures required by Items 7 through 11 of Form N-CSR, which includes the financial statements, financial highlights, and other important information when applicable.